Abstract
The diagnosis and staging of severity of the diabetic neuropathy plays an important role not only for following up patients in a daily clinical practice, but also for the conduction of research that studies the etiopathogenesis of the disease and the development of new therapeutic modalities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Consensus Statement Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes 1988;37:1000–1004.
Melzack R. The McGill Pain Questionnaire, major properties and scoring methods. Pain 1974;1:277–299.
Masson EA, Hunt L, Gem JM, Boulton AJM. A novel approach to the diagnosis and assessment of symptomatic diabetic neuropathy. Pain 1989;38:25–28.
Scott J, Huskisson EC. Graphic representation of pain. Pain 1976;2:175–184.
Boulton AJM, Scarpello JHB, Armstrong WD, Ward JD. The natural history of painful diabetic neuropathy —a 4-year study. Postgrad Med J 1983;59:16–19.
Dyck PJ, Sherman WR, Hallcher LM, Service J, O’Brian PC, Grina LC, Palumbo PJ, Swanson CJ. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590–596.
Dyck PJ, Karnes J, O’Brien PC, Swanson CJ. Neuropathy symptom profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology 1986;36:1300–1308.
Tesfaye S, Stevens L, Stephenson J, Fuller JH, Plater M, Ionescu-Tirgoviste C, Nuber A, Pozza G, Ward JD. The prevalence of diabetic peripheral neuropathy and its relation to glycemic control and potential risk factors: the Eurodiab IDDM complication study. Diabetologia 1996;39:1377–1384.
Veves A, Uccioli L, Manes C, Van Acker K, Komninou H, Philippides P, Katsilambros N, De Leeuw I, Menzinger G, Boulton AJM. Comparisons of risk factors for foot problems in diabetic patients attending teaching hospitals outpatient clinics in four different European states. Diabetic Med 1994;11:709–713.
Veves A, Donaghue VM, Sarnow MR, Giurini JM, Campbell DR, LoGerfo FW. The impact of reversal of hypoxia by revascularization in the peripheral nerve function of diabetic patients. Diabetologia 1996;39:344–348.
Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ, O’Brian PC, Litchy WJ, Windebank AJ, Smith BE, Low PA, Service FJ, Rizza RA, Zimmerman BR. The Rochester diabetic neuropathy study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991;41:799–807.
Young RJ, Zhou YQ, Rodriguez E, Prescott RJ, Ewing DJ, Clarke BF. Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy. Diabetes 1986;35:192–197.
Feldman EL, Srevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281–1289.
Steiness IB. Vibratory perception in normal subjects. A biothesiometer study. Acta Med Scandloose 1957;158:327–335.
Bloom S, Till S, Sonksen, Smith S. Use of a biothesiometer to measure individual vibration thresholds and their variation in 519 non-diabetic subjects. Brit Med J 1984;288:1783–1785.
Wiles PG, Pearce SM, Rice PJS, Mitchell JMO. Vibration Perception Threshold: influence of age, height, sex, and smoking and calculation of accurate centile values. Diabetic Med 1991;8:157–161.
Tegner R. The effect of skin temperature on vibratory sensitivity in polyneuropathy. J Neurol Neurosurg Psychiatry 1985;48:176–178.
Valensi P, Attali JR, Gagnat S. Reproducibility of parameters for assessment of diabetic neuropathy. The French Group for Research and Study of Diabetic Neuropathy. Diabetic Med 1993;10:933–939.
Williams G, Gill JS, Aber V, Mather HM. Variability in vibration perception threshold among sites: a potential source of error in biothesiometry. Brit Med J 1988;286:233–235.
Donaghue VM, Giurini JM, Rosenblum BI, Weissman PN, Veves A. Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients. Diabet Res Clin Pract 1995;29:37–42.
Young MJ, Breddy JL, Veves A, Boulton AJM. The prediction of diabetic foot ulceration using vibration thresholds: a prospective study. Diabetes Care 1994;17:557–560.
Sosenko JM, Kato M, Soto R, Bild DE. Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients. Diabetes Care 1990;13:1057–1061.
Birke JA, Sims DS. Plantar sensory threshold in ulcerative foot. Leprosy Rev 1986;57:261–267.
Kumar S, Fernando DJS, Veves A, Knowles EA, Young MJ, Boulton AJM. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 1991;13:63–68.
Ziegler D, Mayer P, Wiefels K, Gries FA. Assessment of small and large fiber function in long-term type 1 (insulin-dependent) diabetic patients with and without painful neuropathy. Pain 1988;34:1–10.
Jamal GA, Weir AI, Hansen S, Ballantyne JP. An improved automated method for the measurement of thermal thresholds. 2. Patients with peripheral neuropathy. J Neurol Neurosurg Psychiatry 1985;48:361–366.
Bertelsmann FW, Heimans JJ, Weber EJM, Van der Veen EA, Schouten JA. Thermal discrimination threshold in normal subjects and in patients with diabetic neuropathy. J Neurol Neurosurg Psychiatry 1985;48:686–690.
Masson EA, Veves A, Fernando D, Boulton AJM. Current perception thresholds: a new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia 1989;32:724–728.
Pitei DL, Watkins PJ, Stevens MJ, Edmonds ME. The value of neurometer is assessing diabetic neuropathy by measurement of the current perception threshold. Diabetic Med 1994;11:872–876.
Veves A, Young MJ, Manes C, Boulton AJM. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy: a clinical study. Diabetes Care 1994;17:1200–1203.
Vinik AI, Suwanwalaikorn S, Stansberry KB, Holland MT, McNitt PM, Colen LE. Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve 1995;18:574–584.
Dyck PJ, Karnes J, O’Brian PC. Detection Thresholds of cutaneous sensation. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D, eds. Diabetic Neuropathy. WB Saunders, Philadelphia, 1987, pp. 107–121.
Kimura J. Nerve conduction studies and electromyography. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral Neuropathy. Saunders, Philadelphia, 1984, pp. 919–966.
Behse F, Buchthal F. Sensory action potentials and biopsy of the sural nerve in neuropathy. Brain 1978;101:473–493.
Baba M. Diabetic nerve function: its electrophysiological evaluation. In: Ward JD, Goto Y, eds. Diabetic Neuropathy. Wiley, Chichester, UK, 1991, pp. 269–280.
Daube JR. Electrophysiologic testing in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D, eds. Diabetic Neuropathy. Saunders, Philadelphia, 1987, pp. 162–176.
Daube JR. Electrophysiologic testing in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D, eds. Diabetic Neuropathy. Saunders, Philadelphia, 1987, pp. 162–176.
Dyck PJ, O’Brian PC. Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy. Diabetes Care 1989;12:649–652.
Consensus Statement. 1996 Standardized measures in diabetic neuropathy. Morphological and biochemical measures. Diabetes Care 1996;19(Suppl 1):S74–S76.
Dyck PJ, Karnes JL, Daube J, O’Brien P, Service FJ. Clinical and neuropathological criteria for the diagnosis and staging of diabetic neuropathy. Brain 1985;1985:861–880.
Veves A, Malik RA, Lye RH, Masson EA, Sharma AK, Schady W, Boulton AJM. Correlations between sural nerve histology and electrophysiology and quantitative sensory tests in mild diabetic neuropathy. Diabetic Med 1991;8:917–921.
Dyck PJ, Bushek W, Spring EM, Karnes JL, Litchy J O’Brien P, Service FJ. Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care 1987;10:432–440.
Veves A, Young MJ, Manes C, Boulton AJM. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy: a clinical study. Diabetes Care 1994;17:1200–1203.
Veves A, Manes C, Murray HJ, Young MJ, Boulton AJM. Painful neuropathy in diabetic patients with or without foot ulceration. Diabetes Care 1993;16:1187–1189.
Britland ST, Young RJ, Sharma AK, Clarke BF. Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration. Diabetes 1990;39:898–908.
Malik RA, Newrick PG, Sharma AK, Jennings A, Ah-See AK, Mayhew TM, Jakubowski J, Boulton AJM, Ward JD. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 1989;32:92–102.
Behse F, Buchthal F, Carlsen F. Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 1977;40:1072–1082.
Ward JD, Fisher DJ, Barnes CG, Jessop JD. Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet 1971;1:428–430.
Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 1988;11:21–32.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Veves, A. (1998). Diagnosis of Diabetic Neuropathy. In: Veves, A. (eds) Clinical Management of Diabetic Neuropathy. Contemporary Endocrinology, vol 7. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-1816-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1816-6_4
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-7296-0
Online ISBN: 978-1-4612-1816-6
eBook Packages: Springer Book Archive